Status:

UNKNOWN

Development Cellular Models of the Ear and Nose to Study the Mechanisms of Hearing

Lead Sponsor:

University Hospital, Brest

Conditions:

Hearing Loss, GJB2, Cis Regulation, DFNB1

Eligibility:

All Genders

18-60 years

Brief Summary

Development of cells culturesissued from Nose and Ear to study auditory mecanisms. Study of the cis-Modulation of the gene GJB2 for the patients with early presbycusis to identify the genetic cause o...

Eligibility Criteria

Inclusion

  • Hearing loss Presbycusis Exostosis

Exclusion

  • Genetic hearing loss

Key Trial Info

Start Date :

June 15 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 15 2024

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04823195

Start Date

June 15 2021

End Date

June 15 2024

Last Update

September 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHRU de Brest

Brest, France, 29609